Pathology

Peter VanTuinen, PhD

Associate Professor of Pathology
Director of Clinical Cytogenetics, Dynacare Laboratories

Dr. VanTuinen teaches several classes including: sophomore Pathology, freshman Medical Genetics, and graduate Classical and Molecular Genetics.  He is a member of the MCW Chemical and Hazardous Substance Safety Committee and the MCW Radiation Safety Committee. 

Research Interests

• Cytogenetic and molecular characterization of neoplastic genomic rearrangements
• Comparative primate genomic evolution

Professional Background

• MCW Department of Pathology, Director of Clinical Cytogenetics Laboratory (1990 - present)
• Associate Director, University of Texas Health Sciences Center Clinical Cytogenetics Laboratory (1988 - 1990)
• Consultant, St. Joseph's Hospital Milwaukee Clinical Laboratory (1992 - 1998)

Educational Background

• Postdoctoral Fellowship, Baylor College of Medicine (1985 - 1988)
• PhD, Physical Anthropology, Minor Genetics (1985)
• MS, University of Wisconsin (1978)
• BS, University of Wisconsin (1974)

Board Certifications

• American Board of Medical Genetics (1990)

Selected Publications

• Novoa-Takara L, Dincer A, Kampalath B, VanTuinen P, Hariharan S, Chang C. “Post-transplant lymphoproliferative disorder with Hodgkin’s lymphoma and large B-cell lymphoma differentiation”. Histopathology. 47(3):333-4, 2005 Sept.
• Lawatsch EJ, Datta MW, VanTuinen P, Sudakoff GS, Davis NB, Langenstroer P. “Intra-abdominal desmoids tumor following retroperitoneal lymph node dissection for testicular germ cell tumor”. (Case reports) International Journal of Urology. 13(1):84-6, 2006 Jan.
• Heerema NA, Raimondi SC, Shuster J, Biegel, Camitta, Cooley LD, Gaynon P, Hirsch B, Magenis HE, McGavran L, Patil S, Pettenati MJ, Pullen J, Rao K, Schneider NR, Roulston D, Sanger W, Sather HN, Sather HN, Sutcliffe MJ, VanTuinen P, Watson MS, Carroll AJ. “Extra copy numbers of specific chromosomes occur in an identifiable pattern at each modal number and are cumulative in pediatric acute lymphoblastic leukemia. Genes, Chromosomes & Cancer. 46(7):684-93, 2007
• Walters MP, Olteanu H, MD, VanTuinen P, Kroft SH. CD23 expression in plasma cell myeloma is specific for abnormalities of chromosome 11, and is associated with primary plasma cell leukemia in this cytogenetic sub-group. Accepted for Publication, Brit. J. Haem 2009.
• Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, and Fenske TS. Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy. Submitted for Publication, 2009.